$7.90 -0.07 (-0.88%) Corcept Therapeutics Inc - NASDAQ

Dec. 8, 2016 | 11:49 AM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 7.90
Trade Time: Dec 08 11:49 AM Eastern Daylight Time
Change: -0.07 (-0.88%)
Prev Close: 7.97
Open: 7.90
Bid: 7.90
Ask: 7.91
  1. No results found.
  1. Top 3 Growth Stocks Under $10

    TalkMarkets | Sep. 29, 2016 | 17:40PM EST
  2. Corcept Therapeutics Announces Preliminary Fourth Quarter and Full Year 2015 Summary Financial ...

    GuruFocus | Jan. 28, 2016 | 23:04PM EST
  3. Corcept Therapeutics to Announce Preliminary 2015 Financial Results, Provide 2016 Revenue ...

    GuruFocus | Jan. 21, 2016 | 23:05PM EST
  4. Mid-Morning Market Update: Markets Edge Lower; Cal-Maine Misses Q2 Expectations

    Benzinga | Dec. 24, 2015 | 10:08AM EST
  5. Corcept Therapeutics Announces Initial Efficacy Results in Phase 1/2 Trial of Mifepristone in ...

    GuruFocus | Dec. 14, 2015 | 23:04PM EST
  6. David Swensen's Transactions Show Diversity of Portfolio

    GuruFocus | Nov. 19, 2015 | 10:28AM EST
  7. Corcept Therapeutics to Announce Third Quarter Financial Results and Corporate Update and Host ...

    GuruFocus | Oct. 29, 2015 | 23:02PM EST
  8. Results of Phase 1 Trial of Next-Generation Cortisol Modulator CORT125134 to Be Presented at ...

    GuruFocus | Oct. 13, 2015 | 23:03PM EST
  9. Corcept Therapeutics Appoints Robert S. Fishman, M.D., as Chief Medical Officer

    GuruFocus | Sep. 28, 2015 | 23:01PM EST
  10. Corcept Therapeutics to Announce Second Quarter Financial Results and Corporate Update and Host ...

    GuruFocus | Jul. 29, 2015 | 23:03PM EST
  11. Mid-Day Market Update: Dow Dips Over 1%; Harley-Davidson Shares Rise On Earnings Beat

    Benzinga | Jul. 21, 2015 | 11:46AM EST
  12. Benzinga's Top Initiations

    Benzinga | Apr. 21, 2015 | 08:36AM EST
  13. Two Stocks for the Value Investor and GAARP Enthusiast

    GuruFocus | Jun. 7, 2014 | 11:54AM EST
  14. Morning Market Losers

    Benzinga | May. 7, 2014 | 08:48AM EST
  15. UPDATE: Stifel Terminates Coverage on Corcept Therapeutics Due to Reallocation of Resources

    Benzinga | Mar. 10, 2014 | 08:40AM EST
Trading Center